Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adeno-associated virus 4

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13206-13213

  Shen, Shen ^a   Troupes, Andrew N ^a   Pulicherla, Nagesh ^a   Asokan, Aravind ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIC ACID; SIALIDASE; SIALOGLYCOPROTEIN; VIRUS HEMAGGLUTININ;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 4; AMINO ACID COMPOSITION; ARTICLE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION; HEART; IN VITRO STUDY; LUNG PARENCHYMA; NONHUMAN; PARVOVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEROTYPE; SIALYLATION; VIRAL CLEARANCE; VIRAL TROPISM; VIRION; VIRUS CAPSID; VIRUS ENTRY; VIRUS GENOME; VIRUS STRAIN;

ANIMALS; CAPSID; CAPSID PROTEINS; DEPENDOVIRUS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLUCANS; HEART; HEK293 CELLS; HUMANS; LUNG; MICE; MICE, INBRED BALB C; N-ACETYLNEURAMINIC ACID; ORGAN SPECIFICITY; PARVOVIRIDAE INFECTIONS; RECEPTORS, VIRUS; VIRAL TROPISM;

EID: 84888031467     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02109-13     Document Type: Article

References (46)

1. Berns K, Parrish CR. 2007. Parvoviridae, p 2437-2477. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol II. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Asokan A, Schaffer DV, Jude Samulski R. 2012. The AAV vector toolkit:poised at the clinical crossroads. Mol. Ther. 20:699-708.
3. Chiorini JA, Yang L, Liu Y, Safer B, Kotin RM. 1997. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J. Virol. 71:6823-6833.
4. Govindasamy L, Padron E, McKenna R, Muzyczka N, Kaludov N, Chiorini JA, Agbandje-McKenna M. 2006. Structurally mapping the diverse phenotype of adeno-associated virus serotype 4. J. Virol. 80:11556-11570.
5. Padron E, Bowman V, Kaludov N, Govindasamy L, Levy H, Nick P, McKenna R, Muzyczka N, Chiorini JA, Baker TS, Agbandje-McKenna M. 2005. Structure of adeno-associated virus type 4. J. Virol. 79:5047-5058.
6. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA. 2001. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75:6884-6893.
7. Walters RW, Pilewski JM, Chiorini JA, Zabner J. 2002. Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J. Biol. Chem. 277:23709-23713.
8. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. 2008. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16:1073-1080.
9. Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA, Zabner J, Ghodsi A, Chiorini JA. 2000. Recombinant adeno-associated virus type 2, 4, and 5 vectors:transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. U.S.A. 97:3428-3432.
10. Agbandje-McKenna M, Kleinschmidt J. 2011. AAV capsid structure and cell interactions. Methods Mol. Biol. 807:47-92.
11. Chapman MS, Agbandje-McKenna M. 2006. Atomic structure of viral particles, p 107-123. In Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR (ed), Parvoviruses. Edward Arnold Ltd, New York, NY.
12. Summerford C, Samulski RJ. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
13. Handa A, Muramatsu S, Qiu J, Mizukami H, Brown KE. 2000. Adenoassociated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J. Gen. Virol. 81:2077-2084.
14. Rabinowitz JE, Rolling F, Li C, Conrath H, Xiao W, Xiao X, Samulski RJ. 2002. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76:791-801.
15. Halbert CL, Allen JM, Miller AD. 2001. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol. 75:6615-6624.
16. Wu Z, Asokan A, Grieger JC, Govindasamy L, Agbandje-McKenna M, Samulski RJ. 2006. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. J. Virol. 80:11393-11397.
17. Shen S, Bryant KD, Brown SM, Randell SH, Asokan A. 2011. Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J. Biol. Chem. 286:13532-13540.
18. Bell CL, Vandenberghe LH, Bell P, Limberis MP, Gao GP, Van Vliet K, Agbandje-McKenna M, Wilson JM. 2011. The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J. Clin. Invest. 121:2427-2435.
19. Wu Z, Miller E, Agbandje-McKenna M, Samulski RJ. 2006. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80:9093-9103.
20. Walters RW, Yi SM, Keshavjee S, Brown KE, Welsh MJ, Chiorini JA, Zabner J. 2001. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276:20610-20616.
21. Pulicherla N, Shen S, Yadav S, Debbink K, Govindasamy L, Agbandje-McKenna M, Asokan A. 2011. Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Mol. Ther. 19:1070-1078.
22. Arnold K, Bordoli L, Kopp J, Schwede T. 2006. The SWISS-MODEL workspace:a web-based environment for protein structure homology modelling. Bioinformatics 22:195-201.
23. Carrillo-Tripp M, Shepherd CM, Borelli IA, Venkataraman S, Lander G, Natarajan P, Johnson JE, Brooks CL, III, Reddy VS. 2009. VIPERdb2:an enhanced and web API enabled relational database for structural virology. Nucleic Acids Res. 37:D436-D442. doi:10.1093/nar/gkn840.
24. Grieger JC, Choi VW, Samulski RJ. 2006. Production and characterization of adeno-associated viral vectors. Nat. Protoc. 1:1412-1428.
25. Opie SR, Warrington KH, Jr, Agbandje-McKenna M, Zolotukhin S, Muzyczka N. 2003. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J. Virol. 77:6995-7006.
26. Ng R, Govindasamy L, Gurda BL, McKenna R, Kozyreva OG, Samulski RJ, Parent KN, Baker TS, Agbandje-McKenna M. 2010. Structural characterization of the dual glycan binding adeno-associated virus serotype 6. J. Virol. 84:12945-12957.
27. O'Donnell J, Taylor KA, Chapman MS. 2009. Adeno-associated virus-2 and its primary cellular receptor-cryo-EM structure of a heparin complex. Virology 385:434-443.
28. Lerch TF, Chapman MS. 2012. Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B). Virology 423:6-13.
29. Levy HC, Bowman VD, Govindasamy L, McKenna R, Nash K, Warrington K, Chen W, Muzyczka N, Yan X, Baker TS, Agbandje-McKenna M. 2009. Heparin binding induces conformational changes in adenoassociated virus serotype 2. J. Struct. Biol. 165:146-156.
30. Bell CL, Gurda BL, Van Vliet K, Agbandje-McKenna M, Wilson JM. 2012. Identification of the galactose binding domain of the AAV9 capsid. J. Virol. 86:7326-7333.
31. Xie Q, Lerch TF, Meyer NL, Chapman MS. 2011. Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6). Virology 420:10-19.
32. Shen S, Bryant K, Sun J, Brown S, Troupes A, Pulicherla N, Asokan A. 2012. Glycan binding avidity determines the systemic fate of adenoassociated virus 9. J. Virol. 86:10408-10417.
33. Bunn-Moreno MM, Campos-Neto A. 1981. Lectin(s) extracted from seeds of Artocarpus integrifolia (jackfruit):potent and selective stimulator( s) of distinct human T and B cell functions. J. Immunol. 127:427-429.
34. Olofsson S, Bergstrom T. 2005. Glycoconjugate glycans as viral receptors. Ann. Med. 37:154-172.
35. Neu U, Bauer J, Stehle T. 2011. Viruses and sialic acids:rules of engagement. Curr. Opin. Struct. Biol. 21:610-618.
36. Chandrasekaran A, Srinivasan A, Raman R, Viswanathan K, Raguram S, Tumpey TM, Sasisekharan V, Sasisekharan R. 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol. 26:107-113.
37. Tomassini JE, Maxson TR, Colonno RJ. 1989. Biochemical characterization of a glycoprotein required for rhinovirus attachment. J. Biol. Chem. 264:1656-1662.
38. Jiang J, Cun W, Wu X, Shi Q, Tang H, Luo G. 2012. Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate. J. Virol. 86:7256-7267.
39. Kalia M, Chandra V, Rahman SA, Sehgal D, Jameel S. 2009. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J. Virol. 83:12714-12724.
40. Vanlandschoot P, Van Houtte F, Serruys B, Leroux-Roels G. 2005. The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate. J. Gen. Virol. 86:75-84.
41. Kern A, Schmidt K, Leder C, Muller OJ, Wobus CE, Bettinger K, Von der Lieth CW, King JA, Kleinschmidt JA. 2003. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol. 77:11072-11081.
42. Di Pasquale G, Davidson BL, Stein CS, Martins I, Scudiero D, Monks A, Chiorini JA. 2003. Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9:1306-1312.
43. Weller ML, Amornphimoltham P, Schmidt M, Wilson PA, Gutkind JS, Chiorini JA. 2010. Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6. Nat. Med. 16:662-664.
44. Asokan A, Hamra JB, Govindasamy L, Agbandje-McKenna M, Samulski RJ. 2006. Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry. J. Virol. 80:8961-8969.
45. Seiradake E, Henaff D, Wodrich H, Billet O, Perreau M, Hippert C, Mennechet F, Schoehn G, Lortat-Jacob H, Dreja H, Ibanes S, Kalatzis V, Wang JP, Finberg RW, Cusack S, Kremer EJ. 2009. The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog. 5:e1000277. doi:10.1371/journal.ppat.1000277.
46. Kotchey NM, Adachi K, Zahid M, Inagaki K, Charan R, Parker RS, Nakai H. 2011. A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction. Mol. Ther. 19:1079-1089.